Longitudinal study of symptom clusters in lung cancer patients with refractory cancer pain during treatment

Abstract

Now temporarily not seen for lung cancer patients with intractable pain symptom group of related research. The aim of this study is to explore the morphology of symptom clusters in patients with refractory lung cancer pain during treatment, and to reflect the changing characteristics of symptom clusters in patients with refractory lung cancer pain. Using Chinese MD Anderson symptom scale and the revised module, lung cancer at baseline (T₁), after treatment 2 weeks (T₂), 1 month after treatment (T₃), and 3 months after treatment (T₄) to measure the following four differences of a variety of symptoms.Through exploratory factor analysis to determine the symptom group. A total of 218 lung cancer patients with refractory cancer pain participated in the study. Six symptom clusters were identified at four time points (somatic-psychological SC, gastrointestinal SC, lung cancer-specific SC, adverse effect SC, sleep deprivation SC, and respiratory SC). Of the six symptom clusters, four remained stable at all time points, and there were differences in symptom clusters at different stages of treatment. Lung cancer number than other types of cancer in patients with refractory pain symptoms, severity and troubled degrees were heavier, different time point, symptoms of existing relative stability, and in dynamic change.